MolNFT v1 · #40332 · protein
Crystal structure of the cia- histone H3-H4 complex
2IO5 · ASF1A protein: “Crystal structure of the cia- histone H3-H4 complex”. X-ray diffraction, 3 pockets (best druggability 0.60). MolNFT v1 #40332 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2IO5
- Type
- protein
- Length
- 307 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- ASF1A protein; Histone H3.1; Histone H4
- UniProt
- Q6IA08, P84233, P62799
- Pockets
- 3 · best druggability 0.60
Structure
x-ray diffraction · 3 distinct chains · 38% helix, 29% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | ASF1A protein | protein | 154 | 12% helix, 51% strand | Q6IA08 |
| B | Histone H3.1 | protein | 76 | 71% helix, 4% strand | P84233 |
| C | Histone H4 | protein | 77 | 57% helix, 8% strand | P62799 |
Pockets
3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 227 | 0.60 | 0.80 | 26 | empty |
| 2 | 137 | 0.44 | 0.76 | 24 | empty |
| 3 | 61 | 0.32 | 0.76 | 13 | empty |
Interfaces
3 interfaces between chains.
- B–C · 2180 Ų buried · 14 hydrogen bonds · protein-protein
- A–B · 951 Ų buried · 18 hydrogen bonds · protein-protein
- A–C · 438 Ų buried · 6 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q6IA08
- Every structure of UniProt P84233
- Every structure of UniProt P62799
- Elsewhere: RCSB PDB 2IO5 · PDBe 2IO5 · UniProt Q6IA08 · UniProt P84233 · UniProt P62799
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.